About Paired box protein Pax-3
Paired box protein Pax-3 (PAX3) is a protein
from Homo sapiens identified by UniProt accession
P23760, 479 residues long.
MolForge cross-references it against 0 known binders and
542 disease associations.
Target properties
| Protein name | Paired box protein Pax-3 |
| UniProt accession | P23760 |
| Gene | PAX3 |
| Organism | Homo sapiens |
| Length | 479 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (542)
Diseases linked to this target (Open Targets).
- Waardenburg syndrome type 1 · score 0.84
- Waardenburg syndrome type 3 · score 0.78
- craniofacial-deafness-hand syndrome · score 0.73
- Waardenburg syndrome · score 0.67
- alveolar rhabdomyosarcoma · score 0.63
- rhabdomyosarcoma · score 0.51
- hair shape measurement · score 0.50
- Rare genetic deafness · score 0.49
- facial morphology measurement · score 0.47
- hair color · score 0.47
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P23760-F1 | alphafold | PREDICTED | 63.94 | — |
Amino-acid sequence (479 residues)
MTTLAGAVPR MMRPGPGQNY PRSGFPLEVS TPLGQGRVNQ LGGVFINGRP LPNHIRHKIV EMAHHGIRPC VISRQLRVSH GCVSKILCRY QETGSIRPGA IGGSKPKQVT TPDVEKKIEE YKRENPGMFS WEIRDKLLKD AVCDRNTVPS VSSISRILRS KFGKGEEEEA DLERKEAEES EKKAKHSIDG ILSERASAPQ SDEGSDIDSE PDLPLKRKQR RSRTTFTAEQ LEELERAFER THYPDIYTRE ELAQRAKLTE ARVQVWFSNR RARWRKQAGA NQLMAFNHLI PGGFPPTAMP TLPTYQLSET SYQPTSIPQA VSDPSSTVHR PQPLPPSTVH QSTIPSNPDS SSAYCLPSTR HGFSSYTDSF VPPSGPSNPM NPTIGNGLSP QVMGLLTNHG GVPHQPQTDY ALSPLTGGLE PTTTVSASCS QRLDHMKSLD SLPTSQSYCP PTYSTTGYSM DPVTGYQYGQ YGQSKPWTF
Explore Paired box protein Pax-3 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets